A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.


Nuffield Department of Medicine, University of Oxford, Old Road Campus, Oxford, OX3 7FZ, UK. [Email]


Despite much progress in cancer research, its incidence and mortality continue to rise. A robust biomarker that would predict tumor behavior is highly desirable and could improve patient treatment and prognosis.


Gene signature,Hepatocellular carcinoma,Hypoxia,Pan-cancer,T cells,Tumor-infiltrating lymphocytes,

OUR Recent Articles